Dose selection from Phase 2/3 Duravelo-2 trial and update on potential approval pathway expected in 1Q 2026 as company seeks feedback from multiple regulatory agencies Enhanced clinical leadership ...
NEW YORK, NY – At the Transforming Infrastructure Performance (TIP) Summit held here, Lieutenant Governor Aruna K. Miller took center stage to spotlight Maryland’s rapid and compassionate response to ...
Bicycle Therapeutics plc (NASDAQ: BCYC), a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback